Cargando…

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, Simon D, Sharman, Joanna L, Faccenda, Elena, Southan, Chris, Pawson, Adam J, Ireland, Sam, Gray, Alasdair J G, Bruce, Liam, Alexander, Stephen P H, Anderton, Stephen, Bryant, Clare, Davenport, Anthony P, Doerig, Christian, Fabbro, Doriano, Levi-Schaffer, Francesca, Spedding, Michael, Davies, Jamie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753190/
https://www.ncbi.nlm.nih.gov/pubmed/29149325
http://dx.doi.org/10.1093/nar/gkx1121
_version_ 1783290225952292864
author Harding, Simon D
Sharman, Joanna L
Faccenda, Elena
Southan, Chris
Pawson, Adam J
Ireland, Sam
Gray, Alasdair J G
Bruce, Liam
Alexander, Stephen P H
Anderton, Stephen
Bryant, Clare
Davenport, Anthony P
Doerig, Christian
Fabbro, Doriano
Levi-Schaffer, Francesca
Spedding, Michael
Davies, Jamie A
author_facet Harding, Simon D
Sharman, Joanna L
Faccenda, Elena
Southan, Chris
Pawson, Adam J
Ireland, Sam
Gray, Alasdair J G
Bruce, Liam
Alexander, Stephen P H
Anderton, Stephen
Bryant, Clare
Davenport, Anthony P
Doerig, Christian
Fabbro, Doriano
Levi-Schaffer, Francesca
Spedding, Michael
Davies, Jamie A
author_sort Harding, Simon D
collection PubMed
description The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). As previously described, our unique model of content selection and quality control is based on 96 target-class subcommittees comprising 512 scientists collaborating with in-house curators. This update describes content expansion, new features and interoperability improvements introduced in the 10 releases since August 2015. Our relationship matrix now describes ∼9000 ligands, ∼15 000 binding constants, ∼6000 papers and ∼1700 human proteins. As an important addition, we also introduce our newly funded project for the Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb, www.guidetoimmunopharmacology.org). This has been ‘forked’ from the well-established GtoPdb data model and expanded into new types of data related to the immune system and inflammatory processes. This includes new ligands, targets, pathways, cell types and diseases for which we are recruiting new IUPHAR expert committees. Designed as an immunopharmacological gateway, it also has an emphasis on potential therapeutic interventions.
format Online
Article
Text
id pubmed-5753190
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57531902018-01-05 The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY Harding, Simon D Sharman, Joanna L Faccenda, Elena Southan, Chris Pawson, Adam J Ireland, Sam Gray, Alasdair J G Bruce, Liam Alexander, Stephen P H Anderton, Stephen Bryant, Clare Davenport, Anthony P Doerig, Christian Fabbro, Doriano Levi-Schaffer, Francesca Spedding, Michael Davies, Jamie A Nucleic Acids Res Database Issue The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, www.guidetopharmacology.org) and its precursor IUPHAR-DB, have captured expert-curated interactions between targets and ligands from selected papers in pharmacology and drug discovery since 2003. This resource continues to be developed in conjunction with the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS). As previously described, our unique model of content selection and quality control is based on 96 target-class subcommittees comprising 512 scientists collaborating with in-house curators. This update describes content expansion, new features and interoperability improvements introduced in the 10 releases since August 2015. Our relationship matrix now describes ∼9000 ligands, ∼15 000 binding constants, ∼6000 papers and ∼1700 human proteins. As an important addition, we also introduce our newly funded project for the Guide to IMMUNOPHARMACOLOGY (GtoImmuPdb, www.guidetoimmunopharmacology.org). This has been ‘forked’ from the well-established GtoPdb data model and expanded into new types of data related to the immune system and inflammatory processes. This includes new ligands, targets, pathways, cell types and diseases for which we are recruiting new IUPHAR expert committees. Designed as an immunopharmacological gateway, it also has an emphasis on potential therapeutic interventions. Oxford University Press 2018-01-04 2017-11-15 /pmc/articles/PMC5753190/ /pubmed/29149325 http://dx.doi.org/10.1093/nar/gkx1121 Text en © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Database Issue
Harding, Simon D
Sharman, Joanna L
Faccenda, Elena
Southan, Chris
Pawson, Adam J
Ireland, Sam
Gray, Alasdair J G
Bruce, Liam
Alexander, Stephen P H
Anderton, Stephen
Bryant, Clare
Davenport, Anthony P
Doerig, Christian
Fabbro, Doriano
Levi-Schaffer, Francesca
Spedding, Michael
Davies, Jamie A
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title_full The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title_fullStr The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title_full_unstemmed The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title_short The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
title_sort iuphar/bps guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology
topic Database Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753190/
https://www.ncbi.nlm.nih.gov/pubmed/29149325
http://dx.doi.org/10.1093/nar/gkx1121
work_keys_str_mv AT hardingsimond theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT sharmanjoannal theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT faccendaelena theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT southanchris theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT pawsonadamj theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT irelandsam theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT grayalasdairjg theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT bruceliam theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT alexanderstephenph theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT andertonstephen theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT bryantclare theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT davenportanthonyp theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT doerigchristian theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT fabbrodoriano theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT levischafferfrancesca theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT speddingmichael theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT daviesjamiea theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT theiupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT hardingsimond iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT sharmanjoannal iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT faccendaelena iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT southanchris iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT pawsonadamj iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT irelandsam iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT grayalasdairjg iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT bruceliam iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT alexanderstephenph iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT andertonstephen iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT bryantclare iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT davenportanthonyp iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT doerigchristian iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT fabbrodoriano iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT levischafferfrancesca iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT speddingmichael iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT daviesjamiea iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology
AT iupharbpsguidetopharmacologyin2018updatesandexpansiontoencompassthenewguidetoimmunopharmacology